HPGC Renmintongtai Pharmaceutical Corp (600829) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.063x

Based on the latest financial reports, HPGC Renmintongtai Pharmaceutical Corp (600829) has a cash flow conversion efficiency ratio of -0.063x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-187.38 Million ≈ $-27.42 Million USD) by net assets (CN¥2.99 Billion ≈ $437.97 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 600829 net asset quality score to measure how much of total assets are equity-financed.

HPGC Renmintongtai Pharmaceutical Corp - Cash Flow Conversion Efficiency Trend (1998–2025)

This chart illustrates how HPGC Renmintongtai Pharmaceutical Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check earnings quality score of HPGC Renmintongtai Pharmaceutical Corp to evaluate the quality of earnings relative to operating cash generation.

HPGC Renmintongtai Pharmaceutical Corp Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of HPGC Renmintongtai Pharmaceutical Corp ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Bangkok Chain Hospital Public Company Limited BK:BCH	0.050x
Janux Therapeutics Inc NASDAQ:JANX	-0.013x
Hunan Jingfeng Pharmaceutical SHE:000908	-3.332x
IPERIONX LTD SP.ADR/10 F:30Z0	N/A
AirAsia X Bhd KLSE:5238	-4.848x
KSB SE & Co. KGaA F:KSB3	0.022x
UNITIL Corporation NYSE:UTL	0.026x
Yuanta Futures Co Ltd TWO:6023	0.030x

Annual Cash Flow Conversion Efficiency for HPGC Renmintongtai Pharmaceutical Corp (1998–2025)

The table below shows the annual cash flow conversion efficiency of HPGC Renmintongtai Pharmaceutical Corp from 1998 to 2025. For the full company profile with market capitalisation and key ratios, see HPGC Renmintongtai Pharmaceutical Corp stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥3.01 Billion ≈ $441.19 Million	CN¥299.98 Million ≈ $43.90 Million	0.099x	+148.33%
2024-12-31	CN¥2.88 Billion ≈ $421.60 Million	CN¥115.44 Million ≈ $16.89 Million	0.040x	-66.89%
2023-12-31	CN¥2.75 Billion ≈ $402.61 Million	CN¥332.99 Million ≈ $48.73 Million	0.121x	-3.02%
2022-12-31	CN¥2.46 Billion ≈ $360.36 Million	CN¥307.33 Million ≈ $44.97 Million	0.125x	+217.79%
2021-12-31	CN¥2.20 Billion ≈ $321.82 Million	CN¥-233.00 Million ≈ $-34.10 Million	-0.106x	-2188.91%
2020-12-31	CN¥1.99 Billion ≈ $291.54 Million	CN¥-9.22 Million ≈ $-1.35 Million	-0.005x	+97.92%
2019-12-31	CN¥1.85 Billion ≈ $270.31 Million	CN¥-411.60 Million ≈ $-60.23 Million	-0.223x	-196.07%
2018-12-31	CN¥1.58 Billion ≈ $231.19 Million	CN¥366.45 Million ≈ $53.62 Million	0.232x	+168.84%
2017-12-31	CN¥1.61 Billion ≈ $235.89 Million	CN¥139.07 Million ≈ $20.35 Million	0.086x	+208.97%
2016-12-31	CN¥1.65 Billion ≈ $241.12 Million	CN¥46.01 Million ≈ $6.73 Million	0.028x	-88.10%
2015-12-31	CN¥1.42 Billion ≈ $208.27 Million	CN¥333.99 Million ≈ $48.87 Million	0.235x	+28.70%
2014-12-31	CN¥2.15 Billion ≈ $315.05 Million	CN¥392.58 Million ≈ $57.45 Million	0.182x	+360.00%
2013-12-31	CN¥2.26 Billion ≈ $330.33 Million	CN¥-158.31 Million ≈ $-23.17 Million	-0.070x	-172.98%
2012-12-31	CN¥2.31 Billion ≈ $337.41 Million	CN¥221.57 Million ≈ $32.42 Million	0.096x	+271.75%
2011-12-31	CN¥1.94 Billion ≈ $283.25 Million	CN¥-108.30 Million ≈ $-15.85 Million	-0.056x	-159.69%
2010-12-31	CN¥1.74 Billion ≈ $254.43 Million	CN¥162.99 Million ≈ $23.85 Million	0.094x	-65.32%
2009-12-31	CN¥1.66 Billion ≈ $242.41 Million	CN¥447.82 Million ≈ $65.53 Million	0.270x	+776.00%
2008-12-31	CN¥1.65 Billion ≈ $241.27 Million	CN¥-65.93 Million ≈ $-9.65 Million	-0.040x	-129.42%
2007-12-31	CN¥1.41 Billion ≈ $205.71 Million	CN¥191.10 Million ≈ $27.96 Million	0.136x	-22.95%
2006-12-31	CN¥1.08 Billion ≈ $158.53 Million	CN¥191.13 Million ≈ $27.97 Million	0.176x	-49.94%
2005-12-31	CN¥888.23 Million ≈ $129.98 Million	CN¥313.04 Million ≈ $45.81 Million	0.352x	+504.14%
2004-12-31	CN¥1.04 Billion ≈ $152.24 Million	CN¥60.69 Million ≈ $8.88 Million	0.058x	-54.38%
2003-12-31	CN¥560.39 Million ≈ $82.00 Million	CN¥71.65 Million ≈ $10.48 Million	0.128x	-47.23%
2002-12-31	CN¥526.17 Million ≈ $77.00 Million	CN¥127.49 Million ≈ $18.66 Million	0.242x	+720.86%
2001-12-31	CN¥501.11 Million ≈ $73.33 Million	CN¥14.79 Million ≈ $2.16 Million	0.030x	-77.75%
2000-12-31	CN¥466.36 Million ≈ $68.24 Million	CN¥61.85 Million ≈ $9.05 Million	0.133x	-3.81%
1999-12-31	CN¥422.13 Million ≈ $61.77 Million	CN¥58.21 Million ≈ $8.52 Million	0.138x	+44.85%
1998-12-31	CN¥430.69 Million ≈ $63.02 Million	CN¥41.00 Million ≈ $6.00 Million	0.095x	--

About HPGC Renmintongtai Pharmaceutical Corp

SHG:600829 China Drug Manufacturers - Specialty & Generic

Market Cap

$878.26 Million

CN¥6.00 Billion CNY

Market Cap Rank

#9472 Global

#2391 in China

Share Price

CN¥10.35

Change (1 day)

+9.99%

52-Week Range

CN¥7.76 - CN¥17.72

All Time High

CN¥17.72